Viking Therapeutics, Inc. NASDAQ:VKTX

Viking Therapeutics stock price today

$24.4
-16.75
-40.72%
Financial Health
0
1
2
3
4
5
6
7
8
9

Viking Therapeutics stock price monthly change

-28.02%
month

Viking Therapeutics stock price quarterly change

-28.02%
quarter

Viking Therapeutics stock price yearly change

+109.57%
year

Viking Therapeutics key metrics

Market Cap
4.56B
Enterprise value
1.32B
P/E
-19.23
EV/Sales
N/A
EV/EBITDA
-19.82
Price/Sales
N/A
Price/Book
9.35
PEG ratio
1.02
EPS
-0.92
Revenue
N/A
EBITDA
-114.21M
Income
-93.72M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Viking Therapeutics stock price history

Viking Therapeutics stock forecast

Viking Therapeutics financial statements

Average Price Target
Last Year

$98

Potential upside: 301.63%

Based on estimate of 3 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Viking Therapeutics, Inc. (NASDAQ:VKTX): Profit margin
Jun 2023 0 -19.22M
Sep 2023 0 -22.53M
Dec 2023 436K -24.60M -5643.35%
Mar 2024 0 -27.35M
Viking Therapeutics, Inc. (NASDAQ:VKTX): Earnings per share (EPS)
2023-04-26 -0.26042 -0.25
Viking Therapeutics, Inc. (NASDAQ:VKTX): Debt to assets
Jun 2023 400693000 14.57M 3.64%
Sep 2023 382663000 14.42M 3.77%
Dec 2023 368490000 20.07M 5.45%
Mar 2024 967518000 33.62M 3.48%
Viking Therapeutics, Inc. (NASDAQ:VKTX): Cash Flow
Jun 2023 -11.43M -204.48M 267.07M
Sep 2023 -19.65M -12.53M -74K
Dec 2023 -17.64M 35.73M 188K
Mar 2024 -6.13M -459.79M 606.03M

Viking Therapeutics alternative data

Viking Therapeutics, Inc. (NASDAQ:VKTX): Employee count
Sep 2023 22
Oct 2023 22
Nov 2023 23
Dec 2023 23
Jan 2024 23
Feb 2024 23
Mar 2024 27
Apr 2024 27
May 2024 28
Jun 2024 28
Jul 2024 28

Viking Therapeutics other data

43.23% -7.22%
of VKTX is owned by hedge funds
31.01M -5.17M
shares is hold by hedge funds

Viking Therapeutics, Inc. (NASDAQ:VKTX): Insider trades (number of shares)
Period Buy Sel
Mar 2023 0 524804
Apr 2023 0 476872
May 2023 0 101000
Jan 2024 0 165000
Transaction Date Insider Security Shares Price per share Total value Source
Option
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 85,000 $1.23 $104,550
Option
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 85,000 $1.23 $104,550
Sale
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 40,000 $24.45 $978,000
Sale
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 40,000 $24.45 $978,000
Sale
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 45,000 $24.95 $1,122,750
Sale
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 45,000 $24.95 $1,122,750
Option
LIAN BRIAN director, officer.. Stock Option (right to buy) 85,000 $1.23 $104,550
Option
LIAN BRIAN director, officer.. Stock Option (right to buy) 85,000 $1.23 $104,550
Option
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 35,000 $1.23 $43,050
Option
LIAN BRIAN director, officer.. Common Stock, par value $0.00001 per share 35,000 $1.23 $43,050
Sunday, 29 December 2024
accesswire.com
fool.com
Friday, 27 December 2024
prnewswire.com
Thursday, 26 December 2024
accesswire.com
Tuesday, 24 December 2024
accesswire.com
Saturday, 21 December 2024
fool.com
fool.com
Friday, 20 December 2024
fool.com
Thursday, 19 December 2024
seekingalpha.com
seekingalpha.com
zacks.com
Wednesday, 18 December 2024
benzinga.com
Tuesday, 17 December 2024
accesswire.com
Monday, 16 December 2024
accesswire.com
fool.com
Sunday, 15 December 2024
accesswire.com
fool.com
Friday, 13 December 2024
accesswire.com
accesswire.com
accesswire.com
Wednesday, 11 December 2024
accesswire.com
Tuesday, 10 December 2024
fool.com
Thursday, 5 December 2024
seekingalpha.com
fool.com
Tuesday, 3 December 2024
prnewswire.com
fool.com
fool.com
Friday, 29 November 2024
benzinga.com
Thursday, 28 November 2024
fool.com
Wednesday, 27 November 2024
accesswire.com
  • What's the price of Viking Therapeutics stock today?

    One share of Viking Therapeutics stock can currently be purchased for approximately $24.4.

  • When is Viking Therapeutics's next earnings date?

    Unfortunately, Viking Therapeutics's (VKTX) next earnings date is currently unknown.

  • Does Viking Therapeutics pay dividends?

    No, Viking Therapeutics does not pay dividends.

  • How much money does Viking Therapeutics make?

    Viking Therapeutics has a market capitalization of 4.56B. Viking Therapeutics made a loss 85.9M US dollars in net income (profit) last year or -$0.25 on an earnings per share basis.

  • What is Viking Therapeutics's stock symbol?

    Viking Therapeutics, Inc. is traded on the NASDAQ under the ticker symbol "VKTX".

  • What is Viking Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Viking Therapeutics?

    Shares of Viking Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Viking Therapeutics's key executives?

    Viking Therapeutics's management team includes the following people:

    • Dr. Brian Lian Ph.D. Pres, Chief Executive Officer & Director(age: 59, pay: $878,000)
  • How many employees does Viking Therapeutics have?

    As Jul 2024, Viking Therapeutics employs 28 workers, which is 4% more then previous quarter.

  • When Viking Therapeutics went public?

    Viking Therapeutics, Inc. is publicly traded company for more then 10 years since IPO on 28 Apr 2015.

  • What is Viking Therapeutics's official website?

    The official website for Viking Therapeutics is vikingtherapeutics.com.

  • Where are Viking Therapeutics's headquarters?

    Viking Therapeutics is headquartered at 9920 Pacific Heights Boulevard, San Diego, CA.

  • How can i contact Viking Therapeutics?

    Viking Therapeutics's mailing address is 9920 Pacific Heights Boulevard, San Diego, CA and company can be reached via phone at 858 704 4660.

  • What is Viking Therapeutics stock forecast & price target?

    Based on 3 Wall Street analysts` predicted price targets for Viking Therapeutics in the last 12 months, the avarage price target is $98. The average price target represents a 301.63% change from the last price of $24.4.

Viking Therapeutics company profile:

Viking Therapeutics, Inc.

vikingtherapeutics.com
Exchange:

NASDAQ

Full time employees:

30

Industry:

Biotechnology

Sector:

Healthcare

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. It also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.

9920 Pacific Heights Boulevard
San Diego, CA 92121

CIK: 0001607678
ISIN: US92686J1060
CUSIP: 92686J106